跳至主要内容
临床试验/NCT01638832
NCT01638832Unknown不适用

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

Johann Wolfgang Goethe University Hospital1 个研究点 分布在 1 个国家目标入组 572 人开始时间: 2012年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
572
试验地点
1
主要终点
Liver fibrosis scores I-IV (METAVIR)

研究概览

简要总结

This study will evaluate the association of non-alcoholic fatty liver disease and coronary artery disease. All patients presenting for coronary angiogram will receive the following examination:

  • Transient Elastography and Controlled Attenuation Parameter using the FibroScan
  • blood examination including biochemical markers The results of non-invasive liver steatosis and fibrosis measurement are compared with the results of coronary angiogram concerning the presence or absence of coronary artery disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, 18 years and older
  • Written consent
  • Coronary angiogram planned

排除标准

  • Patients with mental diseases
  • Pregnancy or lactation

结局指标

主要结局

Liver fibrosis scores I-IV (METAVIR)

METAVIR fibrosis scores: I = mild fibrosis II = significant fibrosis III = advanced fibrosis IV = cirrhosis

次要结局

  • Steatosis fibrosis scores I-III

研究者

发起方
Johann Wolfgang Goethe University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验